CuraSen Therapeutics Funding: $60M Raised, Series B (2024)

CuraSen Therapeutics funding overview

CuraSen Therapeutics is based in San Mateo. CuraSen Therapeutics has raised $60M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in August 2024. The round record for CuraSen Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include New Leaf Venture Partners, Longitude Capital, Tekla Capital Management LLC, Alta Partners, Johnson & Johnson Innovation – JJDC, Inc., Pappas Capital and 2 others. 8 distinct backers are named across the disclosed rounds.

CuraSen Therapeutics at a glance

Total raised: $60M
Latest round: Series B
Latest round date: August 2024
Headquarters: San Mateo
Notable investors: New Leaf Venture Partners, Longitude Capital, Tekla Capital Management LLC, Alta Partners, Johnson & Johnson Innovation – JJDC, Inc., Pappas Capital, Access Biotechnology, Domain Associates

Frequently asked about CuraSen Therapeutics funding

How much has CuraSen Therapeutics raised?: CuraSen Therapeutics has raised $60M in total disclosed funding across the rounds on record.
Who has invested in CuraSen Therapeutics?: New Leaf Venture Partners, Longitude Capital, Tekla Capital Management LLC, Alta Partners, Johnson & Johnson Innovation – JJDC, Inc., Pappas Capital are named among the investors backing CuraSen Therapeutics.
What was the latest CuraSen Therapeutics funding round?: The most recent disclosed round is a Series B, announced in August 2024.
Where is CuraSen Therapeutics based?: CuraSen Therapeutics is based in San Mateo.
When did CuraSen Therapeutics last raise?: The last disclosed CuraSen Therapeutics round closed in August 2024 at Series B.

CuraSen Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in San Mateo below to benchmark round size and investor mix.

CuraSen Therapeutics Funding: $60M Raised, Series B (2024)

CuraSen Therapeutics funding overview

CuraSen Therapeutics at a glance

Frequently asked about CuraSen Therapeutics funding

Companies related to CuraSen Therapeutics (32)

Browse related funding lists (6)